Research Presentation Sessions: Oncologic Imaging
Genito-urinary tumours
Lectures
1
Introduction by the moderator - Davide Prezzi, London / UK
02:00
2
Repeatability of quantitative individual lesion and total disease multiparametric whole-body MRI measurements in prostate cancer bone metastases - Ricardo Donners, Basel / CH
08:00
3
Hyperpolarised 13C-pyruvate MRI as a non-invasive read-out of tumour grade in renal cell carcinoma - Stephan Ursprung, Tübingen / DE
08:00
4
Early reduction in spectral dual-layer detector CT parameters as favourable imaging biomarkers in patients with metastatic renal cell carcinoma - Aska Drljevic-Nielsen, Aarhus N / DK
08:00
5
Evaluation of immunotherapy response with CT histogram analysis in metastatic Renal Cell Carcinoma - Sıla Cankaya, Ankara / TR
08:00
6
Validation of PI-RADS v2 for detection of prostate cancer among readers with different degree of experience using US/MRI fusion guided prostate biopsy as reference standard - Jinxing Yu, Richmond / US
08:00
7
The estimated volume index (EVI); a new practical approach for treatment response monitoring in advanced ovarian cancer patients treated with neoadjuvant chemotherapy - Eva Berardi, roma / IT
08:00
8
CT radiomic based models to predict residual disease and early recurrence in primary debulked ovarian cancer - Gregorio Aluffi, Verona / IT
08:00
9
Histogram analysis for characterisation of indeterminate adrenal nodules - Abdellatif Masmoudi, tunis / TN
08:00
